Chronic Non-specific Neck PainNCT06814808
Comparison of Three Different Myofascial Trigger Point Treatments in Chronic Non-Specific Neck Pain
A study testing Conventional Therapy, Ischemic Compression Group and Strain-Counter Strain in people with Chronic Non-specific Neck Pain, run by Biruni University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain [SCS]), and integrated neuromuscular inhibition technique (INIT) applications on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia… Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Chronic Non-specific Neck Pain
- What is being tested?
- Conventional Therapy, Ischemic Compression Group and Strain-Counter Strain
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 51 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 15 Dec 2024to 15 Dec 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The patient is between 18 and 65 years of age,
- The patient presents to the outpatient clinic with a complaint of neck pain that has been persisting for at least 3 months,
- Pain intensity higher than 3.5/10 cm according to the Visual Analogue Scale,
- Active trigger point in at least one of the upper trapezius, levator scapulae, splenius capitus, lower trapezius muscles that may cause neck pain,
- Neck Disability Index total score higher than 15,
- Having the ability to read and write in Turkish was determined as the inclusion criteria.
Who cannot join
- Has had a neck, spine or shoulder injury within the last 6 months,
- The patient has neck pain caused by inflammatory, hormonal, neurological disorders or after trauma,
- Positive radicular findings compatible with nerve root compression, history of spinal fracture, spinal tumours and related malignancies, congenital spinal anomalies,
- History of neck, upper thoracic spine and shoulder surgery,
- Scoliosis surgery or a health problem that causes limitation in spinal mobility,
- Diagnosed with any malignant condition, systemic, neurological or rheumatological disease,
Show all 11Show fewer
- Having a skin disease or hearing-vision problem that may affect the assessment process,
- Uncontrolled hypertension, uncontrolled diabetes mellitus, meniere's disease and vertigo,
- Physiotherapy sessions for neck pain in the last month,
- Pregnancy,
- Use of any analgesic or psychotropic agent was determined as exclusion criteria.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Biruni University
Istanbul, Zeytinburnu, 34015
About this study
Official title: Comparison of Three Different Myofascial Trigger Point Treatments on Pain, Range of Motion, Joint Position Sense and Quality of Life in Chronic Non-specific Neck Pain
The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain [SCS]), and integrated neuromuscular inhibition technique (INIT) applications on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia, quality of life and patient satisfaction in addition to conventional treatment for chronic non-specific neck pain.
It is planned to include 51 patients in the study. The included patients will be divided into 3 groups: Group 1 (HR Group), Group 2 (SCS Group) and Group 3 (INIT Group). All three groups will receive a conventional physiotherapy programme 5 times a week for 4 weeks and the same exercise programme 3 days a week for 4 weeks.
Read the detailed description
Chronic neck pain is one of the most common musculoskeletal problems in the general population and is the second most common type of pain after low back pain worldwide. Electrophysiological agents, therapeutic exercise and trigger point therapy techniques are frequently used in chronic non-specific neck pain. There is insufficient evidence in the current literature regarding which trigger point therapy technique is more effective. The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain [SCS]), and integrated neuromuscular inhibition technique (INIT) on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia, quality of life and patient satisfaction in addition to conventional treatment for chronic non-specific neck pain. The study was planned to include 51 patients between the ages of 18-65 years who applied to Gebze Medicalpark Hospital and met the inclusion criteria. The included patients will be randomised and divided into 3 groups: Group 1 (HR Group), Group 2 (SCS Group) and Group 3 (INIT Group). All three groups will receive a conventional physiotherapy programme (TENS, therapeutic ultrasound, hot pack) 5 times a week for 4 weeks and the same exercise programme 3 days a week for 4 weeks. In addition to conventional treatment, Group 1 will receive HR for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles, Group 2 will receive SCS for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles and Group 3 will receive INIT for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles 3 sessions per week for 4 weeks (12 sessions in total). As evaluation criteria, visual analogue scale will be used to evaluate the intensity of pain felt at rest, activity and at night, and algometer will be used to objectively measure pain threshold and tolerance. Cervical range of motion and joint position sense will be assessed using CROM III-Cervical Range of Motion device. Disability level will be assessed using the Neck Disability Scale, fear of movement using the Tampa Kinesiophobia Scale, quality of life using the Short Form-12, and Global Change Scale to assess patient satisfaction. Assessments will be made before starting the treatment programme and after the completion of the 4-week treatment programme.
- Conditions
- Chronic Non-specific Neck Pain
- Being tested
- Conventional Therapy, Ischemic Compression Group, Strain-Counter Strain, Integrated Neuromuscular Inhibition Technique (INIT)
- Keywords
- Strain Counterstrain, Integrated Neuromuscular Inhibition Technique, Ischaemic compression, Chronic non-specific neck pain, Manual therapy, Exercise, Conventional physiotherapy programme
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Conventional TherapyOther
All three groups will receive a conventional physiotherapy program (TENS, therapeutic ultrasound, hot pack) 5 times a week for 4 weeks and the same exercise program 3 days a week for 4 weeks.
Ischemic Compression GroupOther
The ischemic compression group will receive ischemic compression therapy for the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles.
Strain-Counter StrainOther
The strain counterstrain technique will be applied to the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles.
Integrated Neuromuscular Inhibition Technique (INIT)Other
This group will be subjected to INIT for the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles, 3 sessions per week for 4 weeks (12 sessions in total).
| Study group | Role | What they receive |
|---|---|---|
| Ischaemic Compression Group | Active comparator | Ischaemic compression Manual therapy Receives: Other: Conventional Therapy; Other: Ischemic Compression Group |
| Strain Counterstrain Group | Experimental | Strain Counterstrain Manual therapy Receives: Other: Conventional Therapy; Other: Strain-Counter Strain |
| Integrated Neuromuscular Inhibition Technique Group | Experimental | Integrated Neuromuscular Inhibition Technique Manual therapy Receives: Other: Conventional Therapy; Other: Integrated Neuromuscular Inhibition Technique (INIT) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Visual Analogue Scale
The intensity of pain felt in the neck area at rest, during activity (cervical flexion, extension, right and left lateral flexion, right and left rotation) and at night will be evaluated numerically using a visual analogue scale (VAS). Individuals will be told that the number '0' on a 10 cm horizontal line indicates 'no pain' and the number '10' indicates 'unbearable pain'. The place marked by the individual will be determined as pain intensity in cm.
Measured: 4 weeks
Algometer
An Algometer (Baseline Push-Pull Force Gauge®, Fabrication Enterprises, Inc.) will be used to objectively measure pain threshold and tolerance. Before measuring with the algometer, a pressure will be applied to the pulp of the thumb of the hand, which is the control point. Then, a force will be applied to the same point to cause pain so that the subject can distinguish between the sensation of pressure and the sensation of pain. Then, at the C2 spine level, the pressure will be applied vertically to the muscle tissue from the midpoint of the right-left paraspinal muscles and the right-left upper trapezius muscles, increasing the pressure by 1kg/cm2 every three seconds until the subject feels pain. The subject will be told to report when he/she feels pain while applying force with the device (kg/ cm²). This process will be repeated three times and the average value will be calculated.
Measured: 4 weeks
Cervical Joint Position Sense
Cervical joint position sense will be evaluated by head repositioning test using CROM III-Cervical Range of Motion (Performance Attainment Associates, Lindstrom, MN) device. The target position will be 25° flexion, extension, right-left lateral flexion, right-left rotation respectively. The subject will sit on a chair with a straight back, knees flexed 90 degrees and feet flat on the floor. The subject will be asked to close his/her eyes. Then, the subject's neck will be passively flexed 25° in a slow rhythm, and the position will be maintained for 5 seconds. The subject will be asked to remember this position. Afterwards, the subject's neck will be passively moved to the neutral position in a slow rhythm. The subject will then be instructed to actively move his/her neck and reposition himself/herself in the target position. The subject will signal by saying 'yes' when repositioned to the target position. The deviation in the repositioning test result will be evaluated as joint positi
Measured: 4 weeks
Cervical Range of Motion
Cervical region flexion-extension, right-left lateral flexion and right-left rotation range of motion will be evaluated using the CROM III-Cervical Range of Motion (Performance Attainment Associates, Lindstrom, MN) device. The device has undergone a reliability study and has been reported as a clinically reliable tool for assessing normal range of motion in the cervical region. The subject will be positioned in an upright sitting position on a chair with back support, with the middle and lower back in contact with the chair, feet on the floor and arms comfortably supported on both sides of the chair. The subject will be asked to look straight ahead. After checking the alignment of the nose, mouth, chin and earlobe and making sure that the cervical region is in the anatomical position, the subject will be commanded to start the movement. Each evaluation will be repeated three times and the average value will be recorded.
Measured: 4 weeks
Neck Disability Scale
It will be evaluated with the Neck Disability Scale. The Neck Disability Scale is based on the Oswestry Low Back Pain Disability Index and consists of 10 items. It includes pain sensitivity, personal care, weight lifting, reading, headaches, concentration, work/study, driving, sleep and social activities. Each question has 6 answer options that measure the severity of pain or limitation. Scoring is done between 0-5. The total score is between 0-50. According to the total score, 0-4 points are classified as no limitation; 5-14 as mild limitation; 15-24 as moderate limitation; 25-34 as severe limitation; 34 and above as completely limited. Turkish validity and reliability study was conducted.
Measured: 4 weeks
Tampa Kinesiophobia Scale
Tampa Kinesiophobia Scale (TKS) will be used. TQS is a scale developed to measure the fear of movement/reinjury. It consists of a total of 17 questions. It includes injury/reinjury and fear-avoidance parameters in work-related activities. It consists of 17 questions in total. Total score varies between 17-68. High scores indicate a high level of kinesiophobia. Turkish validity and reliability study was conducted.
Measured: 4 weeks
Short Form-12/ SF-12
Short Form-12 (SF-12) will be used to assess quality of life. SF-12 has 2 total measurements including physical (PCS-12) and mental (MCS-12) components, and high scores indicate good health status. This assessment is a shortened version of SF-36. Turkish validity and reliability studies were conducted.
Measured: 4 weeks
Global Change Scale
It will be evaluated using the Global Change Scale (GTS). In order to evaluate the perceived effect of the treatment applied to the patients, it is used to determine the amount of change considering the current health status after the treatment.
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Feb 2025
- Study start15 Dec 2024
- Primary completion15 Dec 2025 (estimated)
- Study completion15 Dec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Chronic Non-specific Neck PainStudies of the same condition, open and under way.
- More trials run by Biruni UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 51 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Biruni University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Guzin Kaya Aytutuldu, Biruni University
- Investigators
- Tansu Birinci Olgun, Asst prof., Study chair, Medeniyet University, Health Sciences Faculty DepartmentMaryam Zare, MD, Study chair, Medical Park GebzePınar Atamert, MSc, Principal investigator, Biruni University, Health Sciences Faculty Department
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06814808
- Sponsor's protocol ID
- BiruniUni.
- Status last verified
- Feb 2025
- First submitted
- 2 Jan 2025
- Last updated
- 7 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Dardzinski JA, Ostrov BE, Hamann LS. Myofascial pain unresponsive to standard treatment: successful use of a strain and counterstrain technique with physical therapy. J Clin Rheumatol. 2000 Aug;6(4):169-74. doi: 10.1097/00124743-200008000-00001.
PubMed 19078466Hanten WP, Olson SL, Butts NL, Nowicki AL. Effectiveness of a home program of ischemic pressure followed by sustained stretch for treatment of myofascial trigger points. Phys Ther. 2000 Oct;80(10):997-1003.
PubMed 11002435Desai MJ, Bean MC, Heckman TW, Jayaseelan D, Moats N, Nava A. Treatment of myofascial pain. Pain Manag. 2013 Jan;3(1):67-79. doi: 10.2217/pmt.12.78.
PubMed 24645933Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Anesthesiol Clin. 2007 Dec;25(4):841-51, vii-iii. doi: 10.1016/j.anclin.2007.07.003.
PubMed 18054148Simons DG. Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J Electromyogr Kinesiol. 2004 Feb;14(1):95-107. doi: 10.1016/j.jelekin.2003.09.018.
PubMed 14759755Stifano G, Colantuono S, Carusi V, La Marra F, Marra A, Granata M. A case of tension-type headache in fibromyalgia. J Headache Pain. 2010 Aug;11(4):367-8. doi: 10.1007/s10194-010-0218-z. Epub 2010 May 9. No abstract available.
PubMed 20454992
Study at a glance
From the registry record, last updated by the sponsor on 7 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Three Different Myofascial Trigger Point Treatments on Pain, Range of Motion, Joint Position Sense and Quality of Life in Chronic Non-specific Neck Pain
- ClinicalTrials.gov ID
- NCT06814808
- Acronym / sponsor ID
- BiruniUni.
- Conditions
- Chronic Non-specific Neck Pain
- Keywords
- Strain Counterstrain, Integrated Neuromuscular Inhibition Technique, Ischaemic compression, Chronic non-specific neck pain, Manual therapy, Exercise, Conventional physiotherapy programme
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 51 participants (estimated)
- Lead sponsor
- Biruni UniversityUniversity, hospital or other
- Study start
- 15 Dec 2024 (actual)
- Primary completion
- 15 Dec 2025 (estimated)
- Study completion
- 15 Dec 2025 (estimated)
- First posted
- 7 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain [SCS]), and integrated neuromuscular inhibition technique (INIT) applications on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia, quality of life and patient satisfaction in addition to conventional treatment for chronic non-specific neck pain.
It is planned to include 51 patients in the study. The included patients will be divided into 3 groups: Group 1 (HR Group), Group 2 (SCS Group) and Group 3 (INIT Group). All three groups will receive a conventional physiotherapy programme 5 times a week for 4 weeks and the same exercise programme 3 days a week for 4 weeks.
Detailed description
Chronic neck pain is one of the most common musculoskeletal problems in the general population and is the second most common type of pain after low back pain worldwide. Electrophysiological agents, therapeutic exercise and trigger point therapy techniques are frequently used in chronic non-specific neck pain. There is insufficient evidence in the current literature regarding which trigger point therapy technique is more effective. The aim of this study was to compare the efficacy of ischaemic compression (IC), positional relaxation (Strain Counterstrain [SCS]), and integrated neuromuscular inhibition technique (INIT) on pain intensity, pressure pain threshold, range of motion, joint position sense, disability, kinesiophobia, quality of life and patient satisfaction in addition to conventional treatment for chronic non-specific neck pain. The study was planned to include 51 patients between the ages of 18-65 years who applied to Gebze Medicalpark Hospital and met the inclusion criteria. The included patients will be randomised and divided into 3 groups: Group 1 (HR Group), Group 2 (SCS Group) and Group 3 (INIT Group). All three groups will receive a conventional physiotherapy programme (TENS, therapeutic ultrasound, hot pack) 5 times a week for 4 weeks and the same exercise programme 3 days a week for 4 weeks. In addition to conventional treatment, Group 1 will receive HR for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles, Group 2 will receive SCS for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles and Group 3 will receive INIT for upper trapezius, levator scapulae, splenius capitus and lower trapezius muscles 3 sessions per week for 4 weeks (12 sessions in total). As evaluation criteria, visual analogue scale will be used to evaluate the intensity of pain felt at rest, activity and at night, and algometer will be used to objectively measure pain threshold and tolerance. Cervical range of motion and joint position sense will be assessed using CROM III-Cervical Range of Motion device. Disability level will be assessed using the Neck Disability Scale, fear of movement using the Tampa Kinesiophobia Scale, quality of life using the Short Form-12, and Global Change Scale to assess patient satisfaction. Assessments will be made before starting the treatment programme and after the completion of the 4-week treatment programme.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Ischaemic Compression Group | Active comparator | Other: Conventional Therapy, Other: Ischemic Compression GroupIschaemic compression Manual therapy |
| Strain Counterstrain Group | Experimental | Other: Conventional Therapy, Other: Strain-Counter StrainStrain Counterstrain Manual therapy |
| Integrated Neuromuscular Inhibition Technique Group | Experimental | Other: Conventional Therapy, Other: Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique Manual therapy |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- The patient is between 18 and 65 years of age,
- The patient presents to the outpatient clinic with a complaint of neck pain that has been persisting for at least 3 months,
- Pain intensity higher than 3.5/10 cm according to the Visual Analogue Scale,
- Active trigger point in at least one of the upper trapezius, levator scapulae, splenius capitus, lower trapezius muscles that may cause neck pain,
- Neck Disability Index total score higher than 15,
Key exclusion criteria (11 listed)
- Has had a neck, spine or shoulder injury within the last 6 months,
- The patient has neck pain caused by inflammatory, hormonal, neurological disorders or after trauma,
- Positive radicular findings compatible with nerve root compression, history of spinal fracture, spinal tumours and related malignancies, congenital spinal anomalies,
- History of neck, upper thoracic spine and shoulder surgery,
- Scoliosis surgery or a health problem that causes limitation in spinal mobility,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Conventional TherapyAll three groups will receive a conventional physiotherapy program (TENS, therapeutic ultrasound, hot pack) 5 times a week for 4 weeks and the same exercise program 3 days a week for 4 weeks. | Other | Integrated Neuromuscular Inhibition Technique Group, Ischaemic Compression Group, Strain Counterstrain Group |
| Ischemic Compression GroupThe ischemic compression group will receive ischemic compression therapy for the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles. | Other | Ischaemic Compression Group |
| Strain-Counter StrainThe strain counterstrain technique will be applied to the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles. | Other | Strain Counterstrain Group |
| Integrated Neuromuscular Inhibition Technique (INIT)This group will be subjected to INIT for the upper trapezius, levator scapulae, splenius capitis, and lower trapezius muscles, 3 sessions per week for 4 weeks (12 sessions in total). | Other | Integrated Neuromuscular Inhibition Technique Group |
Primary outcome
Visual Analogue Scale
Time frame: 4 weeks
The intensity of pain felt in the neck area at rest, during activity (cervical flexion, extension, right and left lateral flexion, right and left rotation) and at night will be evaluated numerically using a visual analogue scale (VAS). Individuals will be told that the number '0' on a 10 cm horizontal line indicates 'no pain' and the number '10' indicates 'unbearable pain'. The place marked by the individual will be determined as pain intensity in cm.
Algometer
Time frame: 4 weeks
An Algometer (Baseline Push-Pull Force Gauge®, Fabrication Enterprises, Inc.) will be used to objectively measure pain threshold and tolerance. Before measuring with the algometer, a pressure will be applied to the pulp of the thumb of the hand, which is the control point. Then, a force will be applied to the same point to cause pain so that the subject can distinguish between the sensation of pressure and the sensation of pain. Then, at the C2 spine level, the pressure will be applied vertically to the muscle tissue from the midpoint of the right-left paraspinal muscles and the right-left upper trapezius muscles, increasing the pressure by 1kg/cm2 every three seconds until the subject feels pain. The subject will be told to report when he/she feels pain while applying force with the device (kg/ cm²). This process will be repeated three times and the average value will be calculated.
Cervical Joint Position Sense
Time frame: 4 weeks
Cervical joint position sense will be evaluated by head repositioning test using CROM III-Cervical Range of Motion (Performance Attainment Associates, Lindstrom, MN) device. The target position will be 25° flexion, extension, right-left lateral flexion, right-left rotation respectively. The subject will sit on a chair with a straight back, knees flexed 90 degrees and feet flat on the floor. The subject will be asked to close his/her eyes. Then, the subject's neck will be passively flexed 25° in a slow rhythm, and the position will be maintained for 5 seconds. The subject will be asked to remember this position. Afterwards, the subject's neck will be passively moved to the neutral position in a slow rhythm. The subject will then be instructed to actively move his/her neck and reposition himself/herself in the target position. The subject will signal by saying 'yes' when repositioned to the target position. The deviation in the repositioning test result will be evaluated as joint positi
Cervical Range of Motion
Time frame: 4 weeks
Cervical region flexion-extension, right-left lateral flexion and right-left rotation range of motion will be evaluated using the CROM III-Cervical Range of Motion (Performance Attainment Associates, Lindstrom, MN) device. The device has undergone a reliability study and has been reported as a clinically reliable tool for assessing normal range of motion in the cervical region. The subject will be positioned in an upright sitting position on a chair with back support, with the middle and lower back in contact with the chair, feet on the floor and arms comfortably supported on both sides of the chair. The subject will be asked to look straight ahead. After checking the alignment of the nose, mouth, chin and earlobe and making sure that the cervical region is in the anatomical position, the subject will be commanded to start the movement. Each evaluation will be repeated three times and the average value will be recorded.
Neck Disability Scale
Time frame: 4 weeks
It will be evaluated with the Neck Disability Scale. The Neck Disability Scale is based on the Oswestry Low Back Pain Disability Index and consists of 10 items. It includes pain sensitivity, personal care, weight lifting, reading, headaches, concentration, work/study, driving, sleep and social activities. Each question has 6 answer options that measure the severity of pain or limitation. Scoring is done between 0-5. The total score is between 0-50. According to the total score, 0-4 points are classified as no limitation; 5-14 as mild limitation; 15-24 as moderate limitation; 25-34 as severe limitation; 34 and above as completely limited. Turkish validity and reliability study was conducted.
Tampa Kinesiophobia Scale
Time frame: 4 weeks
Tampa Kinesiophobia Scale (TKS) will be used. TQS is a scale developed to measure the fear of movement/reinjury. It consists of a total of 17 questions. It includes injury/reinjury and fear-avoidance parameters in work-related activities. It consists of 17 questions in total. Total score varies between 17-68. High scores indicate a high level of kinesiophobia. Turkish validity and reliability study was conducted.
Short Form-12/ SF-12
Time frame: 4 weeks
Short Form-12 (SF-12) will be used to assess quality of life. SF-12 has 2 total measurements including physical (PCS-12) and mental (MCS-12) components, and high scores indicate good health status. This assessment is a shortened version of SF-36. Turkish validity and reliability studies were conducted.
Global Change Scale
Time frame: 4 weeks
It will be evaluated using the Global Change Scale (GTS). In order to evaluate the perceived effect of the treatment applied to the patients, it is used to determine the amount of change considering the current health status after the treatment.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Feb 2025.
- Background: PubMed 19078466Dardzinski JA, Ostrov BE, Hamann LS. Myofascial pain unresponsive to standard treatment: successful use of a strain and counterstrain technique with physical therapy. J Clin Rheumatol. 2000 Aug;6(4):169-74. doi: 10.1097/00124743-200008000-00001.
- Background: PubMed 11002435Hanten WP, Olson SL, Butts NL, Nowicki AL. Effectiveness of a home program of ischemic pressure followed by sustained stretch for treatment of myofascial trigger points. Phys Ther. 2000 Oct;80(10):997-1003.
- Background: PubMed 24645933Desai MJ, Bean MC, Heckman TW, Jayaseelan D, Moats N, Nava A. Treatment of myofascial pain. Pain Manag. 2013 Jan;3(1):67-79. doi: 10.2217/pmt.12.78.
- Background: PubMed 18054148Lavelle ED, Lavelle W, Smith HS. Myofascial trigger points. Anesthesiol Clin. 2007 Dec;25(4):841-51, vii-iii. doi: 10.1016/j.anclin.2007.07.003.
- Background: PubMed 14759755Simons DG. Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J Electromyogr Kinesiol. 2004 Feb;14(1):95-107. doi: 10.1016/j.jelekin.2003.09.018.
- Background: PubMed 20454992Stifano G, Colantuono S, Carusi V, La Marra F, Marra A, Granata M. A case of tension-type headache in fibromyalgia. J Headache Pain. 2010 Aug;11(4):367-8. doi: 10.1007/s10194-010-0218-z. Epub 2010 May 9. No abstract available.
Related trials for Chronic Non-specific Neck Pain
Active, not recruiting
Multimodal Manual Therapy vs. Maitland Mobilization for Chronic Non-Specific Neck Pain
Chronic Neck Pain
Not yet recruiting
Comparison of the Effectiveness of Motor Imagery Exercises and Suboccipital Myofascial Release Techniques in Nonspecific Chronic Neck Pain
Non-specific Chronic Neck Pain
Active, not recruiting
Cervical Stabilization vs Scapular Clock Exercises for Chronic Non-Specific Neck Pain
Chronic Non-Specific Neck Pain
RecruitingObservational study
Upper Extremity Exercise Capacity in Chronic Non-specific Neck Pain
Neck Pain
Recruiting
Telerehabilitation, Face-to-Face Exercises, and a Mixed Model in Chronic Non-Specific Neck Pain
Chronic Non-specific Neck Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Tansu Birinci Olgun, Asst prof. study chair
Medeniyet University, Health Sciences Faculty Department
Maryam Zare, MD study chair
Medical Park Gebze
Pınar Atamert, MSc principal investigator
Biruni University, Health Sciences Faculty Department
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Conventional Therapy, Ischemic Compression Group and Strain-Counter Strain in people with Chronic Non-specific Neck Pain, run by Biruni University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 7 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Visual Analogue Scale (time frame: 4 weeks). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06814808, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2025.